When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TEVA - Eli Lilly Looks To Positive Data To Expand Its Market Opportunity For Emgality
Teva Pharmaceutical Industries Limited American Depositary Shares
Eli Lilly (LLY) announced that it had achieved a positive outcome in its phase 3 study that used Emgality as a preventative treatment for patients with chronic and episodic migraines. The company is off to a decent start in sales for Emgality, but this latest outcome might help it to increase market share. It won't be easy though, because there are multiple competitors in the very same space. What this latest positive outcome does for patients is that it gives them an alternative option, especially when so many other preventative therapies have failed.